Table 2

Global BV estimates with 95% confidence intervals for hs-cTn derived from (A) all studies that met the meta-analysis inclusion criteria and (B) studies that met the meta-analysis inclusion criteria and had excluded results below LoD.

Healthy
Nonhealthy
Short-term
Long-term
Short-term
Long-term
CVICVGCVICVGCVICVGCVICVG
Ahs-cTnI4.1
(3.4-4.9)
25.0
(23.4-37.7)
15.0
(2.6-16.6)
35.9
(25.9-39.4)
5.0
(3.3-14.0)
156.0
(148.1-187.0)
14.0
(9.2-15.2)
75.4
(35.0-110.0)
hs-cTnT5.6
(1.2-13.4)
36.2
(32.6-47.3)
11.5
(8.3-21.7)
32.2
(26.9-51.2)
3.1
(1.9-12.4)
60.7
(39.4-110.0)
8.8
(7.6-10.9)
69.0
(57.2 - 97.5)
Bhs-cTnI4.3
(3.4-9.0)
36.7
(25.3-81.8)
15.1
(2.6-16.6)
34.6
(25.9-37.9)
5.0
(3.3-14.0)
156.0
(148.1-187.0)
14.1
(9.2-15.0)
63.8
(35.0-126.7)
hs-cTnT5.3
(1.2-14.7)
34.9
(32.6-47.2)
11.3
(8.3-30.5)
26.8
(19.3-47.8)
3.1
(1.9-12.4)
60.7
(39.4-110.0)
8.4
(7.6-10.5)
68.3
(51.8-98.0)
Healthy
Nonhealthy
Short-term
Long-term
Short-term
Long-term
CVICVGCVICVGCVICVGCVICVG
Ahs-cTnI4.1
(3.4-4.9)
25.0
(23.4-37.7)
15.0
(2.6-16.6)
35.9
(25.9-39.4)
5.0
(3.3-14.0)
156.0
(148.1-187.0)
14.0
(9.2-15.2)
75.4
(35.0-110.0)
hs-cTnT5.6
(1.2-13.4)
36.2
(32.6-47.3)
11.5
(8.3-21.7)
32.2
(26.9-51.2)
3.1
(1.9-12.4)
60.7
(39.4-110.0)
8.8
(7.6-10.9)
69.0
(57.2 - 97.5)
Bhs-cTnI4.3
(3.4-9.0)
36.7
(25.3-81.8)
15.1
(2.6-16.6)
34.6
(25.9-37.9)
5.0
(3.3-14.0)
156.0
(148.1-187.0)
14.1
(9.2-15.0)
63.8
(35.0-126.7)
hs-cTnT5.3
(1.2-14.7)
34.9
(32.6-47.2)
11.3
(8.3-30.5)
26.8
(19.3-47.8)
3.1
(1.9-12.4)
60.7
(39.4-110.0)
8.4
(7.6-10.5)
68.3
(51.8-98.0)

A: All studies fulfilling meta-analysis criteria.

B: Studies fulfilling meta-analysis criteria and having excluded results below LoD.

Table 2

Global BV estimates with 95% confidence intervals for hs-cTn derived from (A) all studies that met the meta-analysis inclusion criteria and (B) studies that met the meta-analysis inclusion criteria and had excluded results below LoD.

Healthy
Nonhealthy
Short-term
Long-term
Short-term
Long-term
CVICVGCVICVGCVICVGCVICVG
Ahs-cTnI4.1
(3.4-4.9)
25.0
(23.4-37.7)
15.0
(2.6-16.6)
35.9
(25.9-39.4)
5.0
(3.3-14.0)
156.0
(148.1-187.0)
14.0
(9.2-15.2)
75.4
(35.0-110.0)
hs-cTnT5.6
(1.2-13.4)
36.2
(32.6-47.3)
11.5
(8.3-21.7)
32.2
(26.9-51.2)
3.1
(1.9-12.4)
60.7
(39.4-110.0)
8.8
(7.6-10.9)
69.0
(57.2 - 97.5)
Bhs-cTnI4.3
(3.4-9.0)
36.7
(25.3-81.8)
15.1
(2.6-16.6)
34.6
(25.9-37.9)
5.0
(3.3-14.0)
156.0
(148.1-187.0)
14.1
(9.2-15.0)
63.8
(35.0-126.7)
hs-cTnT5.3
(1.2-14.7)
34.9
(32.6-47.2)
11.3
(8.3-30.5)
26.8
(19.3-47.8)
3.1
(1.9-12.4)
60.7
(39.4-110.0)
8.4
(7.6-10.5)
68.3
(51.8-98.0)
Healthy
Nonhealthy
Short-term
Long-term
Short-term
Long-term
CVICVGCVICVGCVICVGCVICVG
Ahs-cTnI4.1
(3.4-4.9)
25.0
(23.4-37.7)
15.0
(2.6-16.6)
35.9
(25.9-39.4)
5.0
(3.3-14.0)
156.0
(148.1-187.0)
14.0
(9.2-15.2)
75.4
(35.0-110.0)
hs-cTnT5.6
(1.2-13.4)
36.2
(32.6-47.3)
11.5
(8.3-21.7)
32.2
(26.9-51.2)
3.1
(1.9-12.4)
60.7
(39.4-110.0)
8.8
(7.6-10.9)
69.0
(57.2 - 97.5)
Bhs-cTnI4.3
(3.4-9.0)
36.7
(25.3-81.8)
15.1
(2.6-16.6)
34.6
(25.9-37.9)
5.0
(3.3-14.0)
156.0
(148.1-187.0)
14.1
(9.2-15.0)
63.8
(35.0-126.7)
hs-cTnT5.3
(1.2-14.7)
34.9
(32.6-47.2)
11.3
(8.3-30.5)
26.8
(19.3-47.8)
3.1
(1.9-12.4)
60.7
(39.4-110.0)
8.4
(7.6-10.5)
68.3
(51.8-98.0)

A: All studies fulfilling meta-analysis criteria.

B: Studies fulfilling meta-analysis criteria and having excluded results below LoD.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close